C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 85 filers reported holding C4 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,842 | +428.2% | 3,141 | +681.3% | 0.00% | – |
| Q2 2023 | $1,106 | -89.8% | 402 | -88.4% | 0.00% | – |
| Q1 2023 | $10,855 | -83.4% | 3,457 | -68.8% | 0.00% | – |
| Q4 2022 | $65,319 | +625.8% | 11,071 | +1012.7% | 0.00% | – |
| Q3 2022 | $9,000 | -99.3% | 995 | -97.6% | 0.00% | -100.0% |
| Q4 2021 | $1,349,000 | -48.5% | 41,897 | -28.5% | 0.00% | -40.0% |
| Q3 2021 | $2,619,000 | +81.6% | 58,612 | +50.4% | 0.01% | +66.7% |
| Q1 2021 | $1,442,000 | – | 38,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |